Takanosu M, Sato M, Kagawa Y
Nasunogahara Animal Clinic, Ohtawara, Tochigi, Japan.
Vet Comp Oncol. 2014 Jun;12(2):138-42. doi: 10.1111/j.1476-5829.2012.00346.x. Epub 2012 Aug 14.
Here, we describe the establishment of mutant-specific polymerase chain reaction (PCR) for detection of a c-KIT c.1430G>T mutation in feline mast cell tumours. Several mutations in feline c-KIT have been identified, with the c.1430G>T mutation accounting for a significant portion of feline mast cell tumour mutations. The c.1430G>T mutation in c-KIT exon 9 was detected in 15.7% (11 of 70) of samples by mutant-specific PCR but in only 7.1% (5 of 70) by PCR-restriction fragment length polymorphism (RFLP) in the genomic DNA isolated from 70 formalin-fixed paraffin-embedded sections or cells collected by fine needle aspiration. Mutant-specific PCR showed remarkably higher detection rate than did PCR-RFLP. DNA sequence analysis did not always yield identical results to those of mutant-specific PCR, suggesting heterogeneity of tumour cells. Mutant-specific PCR is a valid and efficient screening tool for detection of the c-KIT c.1430G>T point mutation in feline mast cell tumours compared with PCR-RFLP and sequencing analysis.
在此,我们描述了用于检测猫肥大细胞瘤中c-KIT基因c.1430G>T突变的突变特异性聚合酶链反应(PCR)的建立。已在猫c-KIT中鉴定出几种突变,其中c.1430G>T突变在猫肥大细胞瘤突变中占很大比例。通过突变特异性PCR在70个福尔马林固定石蜡包埋切片或细针穿刺收集的细胞中分离的基因组DNA中,检测到c-KIT外显子9中的c.1430G>T突变的样本占15.7%(70个样本中的11个),但通过PCR-限制性片段长度多态性(RFLP)仅检测到7.1%(70个样本中的5个)。突变特异性PCR显示出比PCR-RFLP显著更高的检测率。DNA序列分析并不总是产生与突变特异性PCR相同的结果,这表明肿瘤细胞存在异质性。与PCR-RFLP和测序分析相比,突变特异性PCR是检测猫肥大细胞瘤中c-KIT c.1430G>T点突变的一种有效且高效的筛选工具。